Showing 1321-1330 of 4067 results for "".
Long-Term PNH Management: Addressing Treatment Goals Beyond Symptom Control
https://reachmd.com/programs/medical-industry-feature/long-term-pnh-management-treatment-goals/35652/Patients with paroxysmal nocturnal hemoglobinuria (PNH) require lifelong therapy.1,2 Long-term data on an available treatment option can help address patient goals—not only in treating symptoms, but also long-term complications. Hear from Arati Chand, MD and Bhumika Patel, MD as they review two-yearExpanding Treatment Options in PNH: Expert Approaches to Personalized Care
https://reachmd.com/programs/medical-industry-feature/pnh-expert-approaches-personalized-care/35651/Managing patients with paroxysmal nocturnal hemoglobinuria (PNH) is never a “one-size-fits-all” approach. With the emergence of a therapy like FABHALTA® (iptacopan), which delivers comprehensive control of intravascular and extravascular hemolysis, we have an option to offer to eligible adult patienManagement of Poststroke Epilepsy: An Update
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/management-of-poststroke-epilepsy-an-update/32188/Poststroke seizure management is a clinical and research priority to improve prognosis.Retina Rumble: Debating Modern Treatment Options
https://reachmd.com/programs/cme/retina-rumble-debating-modern-treatment-options/54609/Join this lively case-based debate moderated by Dr. Goldberg on selecting second-generation therapies for retinal diseases with Drs. Modi and Weng.Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
https://reachmd.com/programs/cme/improving-symptoms-in-patients-with-hfref-using-novel-device-therapy/14475/Baroreflex activation therapy (BAT) provides durable and sustained benefits for exercise capacity, functional status, and QoL. Tune in to learn more!Heart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
https://reachmd.com/programs/cme/heart-failure-grand-rounds-3-things-you-need-to-know-about-cardiac-contractility-modulation/14396/What can you do when GDMT isn’t working? Learn about CCM, an implantable device-based therapy that’s improving symptoms and QoL in patients with HF.Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
https://reachmd.com/programs/cme/direct-from-the-heart-failure-clinic-novel-device-therapy-for-patients-with-hfref/14473/Learn about baroreflex activation therapy (BAT), an implantable, FDA-approved cardiac device that’s improving exercise capacity, QoL & more.Ketamine to Treat Alcoholism?
https://reachmd.com/programs/clinicians-roundtable/ketamine-to-treat-alcoholism/3779/Ketamine is a schedule III drug with a long history as an anesthetic. It also is a well-known club drug in the party circuit. How can it be that it has anti-addictive properties and might it be useful to treat alcoholism? Dr. Stephen Ross, director of the Division of Alcoholism & Drug Abuse at BRadiation Therapy & Prostate Imaging
https://reachmd.com/programs/clinicians-roundtable/radiation-therapy-prostate-imaging/3166/Keeping closer tabs on the intrafractional movement of the prostate during radiation therapy will continue to play an increasingly significant role in improving our overall success when treating prostate cancer. So says Dr. Charles Enke, professor and chair of radiation oncology at the University ofPerspectives on Stress Reduction from a Sports Medicine Specialist
https://reachmd.com/programs/primary-care-today/perspectives-on-stress-reduction-from-a-sports-medicine-specialist/6728/Dr. Brian McDonough speaks with guest Dr. John Kelly, Associate Professor of Clinical Orthopaedic Surgery and Director of Undergraduate Orthopaedic Education at the University of Pennsylvania School of Medicine. Dr. Kelly's areas of expertise are two-fold: (1) updating medical professionals with the